These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 1663792)
1. m-Chlorophenylpiperazine as a probe of serotonin function. Kahn RS; Wetzler S Biol Psychiatry; 1991 Dec; 30(11):1139-66. PubMed ID: 1663792 [TBL] [Abstract][Full Text] [Related]
2. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects. Kahn RS; Siever LJ; Gabriel S; Amin F; Stern RG; DuMont K; Apter S; Davidson M Psychiatry Res; 1992 Jul; 43(1):1-12. PubMed ID: 1332094 [TBL] [Abstract][Full Text] [Related]
3. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects. Kahn RS; Kalus O; Wetzler S; Cahn W; Asnis GM; van Praag HM Psychiatry Res; 1990 Aug; 33(2):189-98. PubMed ID: 2243896 [TBL] [Abstract][Full Text] [Related]
4. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Mueller EA; Murphy DL; Sunderland T Psychopharmacology (Berl); 1986; 89(3):388-91. PubMed ID: 3014595 [TBL] [Abstract][Full Text] [Related]
5. Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM Psychopharmacology (Berl); 1990; 100(3):339-44. PubMed ID: 2156278 [TBL] [Abstract][Full Text] [Related]
6. The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Iqbal N; Asnis GM; Wetzler S; Kahn RS; Kay SR; van Praag HM Biol Psychiatry; 1991 Oct; 30(8):770-8. PubMed ID: 1751620 [TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451 [TBL] [Abstract][Full Text] [Related]
8. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615 [TBL] [Abstract][Full Text] [Related]
10. Serotonin function and treatment response to clozapine in schizophrenic patients. Kahn RS; Davidson M; Siever L; Gabriel S; Apter S; Davis KL Am J Psychiatry; 1993 Sep; 150(9):1337-42. PubMed ID: 8394651 [TBL] [Abstract][Full Text] [Related]
11. Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine. Sevy S; Brown SL; Wetzler S; Kotler M; Molcho A; Plutchik R; van Praag HM Psychiatry Res; 1994 Sep; 53(3):219-29. PubMed ID: 7870844 [TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Aloi JA; Insel TR; Mueller EA; Murphy DL Life Sci; 1984 Apr; 34(14):1325-31. PubMed ID: 6708733 [TBL] [Abstract][Full Text] [Related]
13. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers. Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270 [TBL] [Abstract][Full Text] [Related]
14. The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers. Silverstone PH; Rue JE; Franklin M; Hallis K; Camplin G; Laver D; Cowen PJ Int Clin Psychopharmacol; 1994 Sep; 9(3):173-8. PubMed ID: 7814826 [TBL] [Abstract][Full Text] [Related]
15. Serotonin receptor sensitivity and aggression. Wetzler S; Kahn RS; Asnis GM; Korn M; van Praag HM Psychiatry Res; 1991 Jun; 37(3):271-9. PubMed ID: 1891509 [TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder. Khanna S; John JP; Reddy LP Psychoneuroendocrinology; 2001 Feb; 26(2):209-23. PubMed ID: 11087965 [TBL] [Abstract][Full Text] [Related]
17. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM Psychiatry Res; 1991 Apr; 37(1):25-34. PubMed ID: 1650487 [TBL] [Abstract][Full Text] [Related]
18. Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine. Kahn RS; Siever L; Davidson M; Greenwald C; Moore C Psychopharmacology (Berl); 1993; 112(1 Suppl):S90-4. PubMed ID: 7831445 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943 [TBL] [Abstract][Full Text] [Related]
20. Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts. Handelsman L; Kahn RS; Sturiano C; Rinaldi PJ; Gabriel S; Schmeidler JP; Bernstein DP; Siever L; Cooper TB Psychiatry Res; 1998 Jul; 80(1):1-12. PubMed ID: 9727959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]